Related references
Note: Only part of the references are listed.Screening in Lung Cancer: The Latest Evidence
Luis M. Seijo et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2020)
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
P. Garrido et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Genomic profiling in oncology clinical practice
N. Rodriguez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Molecular profiling for precision cancer therapies
Eoghan R. Malone et al.
GENOME MEDICINE (2020)
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas
Chundi Gao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
Deaglan McHugh et al.
INVESTIGATIONAL NEW DRUGS (2019)
Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development
Shan Shan et al.
FRONTIERS IN GENETICS (2019)
PGM5: a novel diagnostic and prognostic biomarker for liver cancer
Yan Jiao et al.
PEERJ (2019)
Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells
Deng Pan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biomarker potential of repetitive-element transcriptome in lung cancer
Macarena Arroyo et al.
PEERJ (2019)
Sequencing of Tumor DNA to Guide Cancer Risk Assessment and Therapy
David H. Spencer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making
Manik Chahal et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma
Jian Xiao et al.
ONCOTARGET (2017)
A novel BMX variant promotes tumor cell growth and migration in lung adenocarcinoma
Ye Wang et al.
ONCOTARGET (2017)
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer
Michael Mattie et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Translating RNA sequencing into clinical diagnostics: opportunities and challenges
Sara A. Byron et al.
NATURE REVIEWS GENETICS (2016)
A survey of best practices for RNA-seq data analysis
Ana Conesa et al.
GENOME BIOLOGY (2016)
Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
Dung-Tsa Chen et al.
PLOS ONE (2015)
Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma
Cheng Zhan et al.
JOURNAL OF THORACIC DISEASE (2015)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
BMX and Its Role in Inflammation, Cardiovascular Disease, and Cancer
Bruno Cenni et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
Molecular Characterization of Iodotyrosine Dehalogenase Deficiency in Patients with Hypothyroidism
Gijs Afink et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)